Systemic sclerosis (scleroderma) – Epidemiological forecasts at
New York, June 03, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Systemic Sclerosis (Scleroderma) – Epidemiological Forecast to 2030” – https://www.reportlinker.com/p06089409/?utm_source= GNW
The signs and symptoms of SSc usually begin with episodes of Raynaud’s phenomenon (RA). The other signs usually appear a few months later in the dcSSc subset and a few years later in the lcSSc subset.
In cHSS, skin involvement is limited to the hands, face, feet and forearms, while in dcSSc it becomes widespread. The most commonly affected organs are the esophagus, heart, lungs, and kidneys (Genetic and Rare Disorders Information Center, 2018).
This report provides an overview of global and historical risk factors, comorbidities and epidemiological trends for SSc in the seven major markets (7 MM: United States, France, Germany, Italy, Spain, United Kingdom and Japan). One-year epidemiological forecast for prevalent cases diagnosed with SSc.
The prevalent cases diagnosed with SSc are segmented by age (18 years and over), sex, subtype (lcSSc and dcSSc), digital vasculopathy (RP and fingertip or DU) and other internal organ involvement (ILD, PAH, renal disease, impairment, gastrointestinal involvement, musculoskeletal involvement and neuromuscular involvement). The report also includes cases of SSc with comorbid malignancy.
The following data describe the epidemiology of SSc. In the 7MM, epidemiologists predict an increase in prevalent diagnosed cases of SSc from 170,921 cases in 2020 to 187,518 cases in 2030, with an AGR of 0.97% over the forecast period. Women accounted for more prevalent diagnosed cases of SSc than men in 7MM and this mainly affects the elderly. These results are consistent with the analyst’s estimate and these trends are reflected in the predictions for prevalent cases diagnosed for 7MM.
– The Systemic Sclerosis (SSc) Epidemiology Report provides an overview of the risk factors and global trends for SSc in the seven major markets (7 MM: US, France, Germany, Italy, Spain, UK United and Japan).
– The report includes a 10-year epidemiological forecast for diagnosed prevalent cases of SSc segmented by sex and age (aged? 18). The prevalent cases diagnosed with SSc are then segmented by subtype (lcSSc and dcSSc), digital vasculopathy (Raynaud’s phenomenon [RP] and ulcers on the fingertips or fingers [DU]) and other damage to internal organs (interstitial lung disease [ILD], pulmonary arterial hypertension [PAH], kidney disease, cardiac involvement, gastrointestinal involvement, musculoskeletal involvement and neuromuscular involvement). The report also includes cases of SSc with comorbid malignancy. The model associated with this report further provides the incident diagnosed cases and the total number of prevalent cases of SSc segmented by age (? 18) and sex.
– The SSc epidemiology report is written and developed by epidemiologists at Master and PhD level.
– The epidemiological report is in-depth, high-quality, transparent and market-driven, providing expert analysis of disease trends in 7MM.
Reasons to buy
The Epidemiology of Systemic Sclerosis series will allow you to –
– Develop business strategies by understanding the trends that shape and drive the global SSC market.
– Quantify patient populations in the global SSc market to improve product design, pricing and launch plans.
– Organize sales and marketing efforts by identifying the age and gender groups that present the best opportunities for SSc therapies in each of the markets covered.
– Understand the size of the SSc population by subtype, digital vasculopathy and other internal organ damage.
Read the full report: https://www.reportlinker.com/p06089409/?utm_source=GNW
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.